A transient ischemic attack, also known as TIA, can be a warning sign of a major stroke. A transient ischemic attack (TIA) is a type of stroke that lasts only for a short period of time. Typically, it can last anywhere from a few minutes to an hour and resolves completely without leaving any permanent damage. TIA is caused by temporary blockage in a blood vessel that supplies the brain, just like a full-fledged stroke. During a TIA, people may experience temporary loss of vision, numbness, weakness, or loss of sensation on one side of the body, slurred speech, and confusion. Like a stroke, TIA is a medical emergency. TIA is characterized by sudden onset of neurological symptoms. It is important to recognize a TIA, because it is warning sign that an individual is at higher risk for a full-fledged stroke in the next 24 hours. A person presenting with symptoms of TIA should seek immediate medical care. The physician will confirm the diagnosis with medical history, physical and neurological examination, and imaging tests such as computed tomography, magnetic resonance imaging, or angiography. Treatment for TIA should be directed at preventing a major stroke and preventing future events from occurring. Treatment may include medications such as antiplatelet drugs and anticoagulants, lifestyle modifications with regard to risk factors, and evaluation for possible surgical interventions. It is important to reduce risk factors, such as smoking, excessive alcohol use, high cholesterol levels, and high blood pressure. It is important to recognize the signs and symptoms of a TIA and to seek immediate medical care. The prompt diagnosis and treatment of TIA can reduce the risk of developing a full-fledged stroke, and reduce the risk of paralysis, speech, and language impairments, and death associated with stroke. Early diagnosis and treatment can improve the outcomes associated with TIA and stroke.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : Exploring the possible roles of TBK1 and its fly ortholog IK2 gene in nervous system function
Fang He, Texas A&M University, United States